Ludwig H J, Storch H
Zentralbl Gynakol. 1986;108(10):607-19.
Preoperative investigations in ovarian cancer have shown that early diagnostic or screening is impossible by means of the leucocyte adherence inhibition test (LAI-test = LAI). However, this test is important for follow-up studies. The LAI can be an additional parameter for individual decision. It in the clinical supervision of patients has been shown that metastasizing and local recurrent tumors can be detected by this test approximately 4-8 weeks before clinical evidence.
卵巢癌的术前检查表明，通过白细胞黏附抑制试验（LAI试验 = LAI）无法进行早期诊断或筛查。然而，该试验对随访研究很重要。LAI可作为个体决策的一个附加参数。在对患者的临床监测中已表明，通过该试验可在临床证据出现前约4 - 8周检测到转移和局部复发肿瘤。
